- Presentations
- 6
- Markets
- 2
Prevymis is a brand of Letermovir marketed by Merck Sharp & Dohme, with 6 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Letermovir
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 240 mg/12 mL injection, 480 mg/24 mL injection, 120 mg oral pellets, 20 mg oral pellets, 240 mg tablet, 480 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Prevymis 240 mg/12 mL injectionIntravenous | Merck Sharp & Dohme | US FDA | Available on request |
| Prevymis 480 mg/24 mL injectionIntravenous | Merck Sharp & Dohme | US FDA | Available on request |
| Prevymis 120 mg oral pelletsOral | Merck Sharp & Dohme | US FDA | Available on request |
| Prevymis 20 mg oral pelletsOral | Merck Sharp & Dohme | US FDA | Available on request |
| Prevymis 240 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Prevymis 480 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Prevymis
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.